Millions in US Use Unapproved GLP-1s and Altered Methods

A significant number of individuals across the United States are turning to unapproved versions of GLP-1 receptor agonists and utilizing these medications in unconventional ways. Driven largely by soaring costs and persistent access barriers, patients are increasingly seeking alternative methods to obtain these popular weight-loss and diabetes treatments.

The high demand for brand-name therapies has created a lucrative market for compounded and unauthorized alternatives. Public health officials and medical professionals have expressed growing concern over the safety, efficacy, and purity of these unregulated products. Many users, struggling to afford authorized prescriptions or facing insurance denials, unknowingly expose themselves to potential health risks by bypassing standard pharmaceutical channels.

Medical experts emphasize that altering dosages or using unapproved formulations can lead to severe adverse effects. Regulatory agencies continue to issue warnings regarding the dangers associated with unverified supply chains. As the popularity of GLP-1 medications remains high, addressing the underlying issues of cost and accessibility is becoming a critical priority for healthcare providers and policymakers alike.

Sources: Ars Technica